Letter: Kudos to Govt for unhindered financial resources to GECOM inewsguyana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inewsguyana.com Daily Mail and Mail on Sunday newspapers.
- BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan - BridgeBio to receive upfront payment of USD 100 million with.
BridgeBio Pharma (BBIO) and Kyowa Kirin Partner $100M Upfront Payment for Exclusive License on Infigratinib in Skeletal Dysplasias in Japan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.